pop3 personal page - To The Moon

pop3

pop3

No personal profile

22Follow

5Followers

0Topic

0Badge

2021-07-30

Same issues with all other streaming channels, wonder how Netflix can make rights exclusive like they do in cinemas

Sorry, the original content has been removed

2021-07-30

Is it really possible?

Beyond Meat: This Stock Is A Really Raw Deal

2021-08-21

$Apple(AAPL)$Is doing well

2021-07-31

Check out undervalue SG stocks

SGD to weaken to $1.35/USD amidst COVID-19 woes: Fitch

2021-08-10

$Apple(AAPL)$like and comment

2021-08-06

$IX BIOPHARMA LTD.(42C.SI)$Soon it will change around

2021-08-05

Nice

Sorry, the original content has been removed

2021-08-02

Buying SQ is a good idea now with plans to do open international flights

2021-07-31

$IX BIOPHARMA LTD.(42C.SI)$Looking at this undervalued sg stock

2021-07-30

$Apple(AAPL)$thanks tiger for free apple stock

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4090242229859660","uuid":"4090242229859660","gmtCreate":1627139846354,"gmtModify":1627655852236,"name":"pop3","pinyin":"pop3","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":22,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.09.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":836493524,"gmtCreate":1629512116468,"gmtModify":1676530062240,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Go growth opportunities&nbsp;","listText":"Go growth opportunities&nbsp;","text":"Go growth opportunities","images":[{"img":"https://static.tigerbbs.com/8ee355c1ac30008caac75a80b2e7fe0c","width":"750","height":"2389"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/836493524","isVote":1,"tweetType":1,"viewCount":2252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":836493144,"gmtCreate":1629512075688,"gmtModify":1676530062224,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Is doing well&nbsp;","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Is doing well&nbsp;","text":"$Apple(AAPL)$Is doing well","images":[{"img":"https://static.tigerbbs.com/4baaf5f90403a983bb9abe9d0f7f6cf9","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/836493144","isVote":1,"tweetType":1,"viewCount":3458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":839065348,"gmtCreate":1629108380284,"gmtModify":1676529932621,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Jushi is looking juicy!&nbsp;","listText":"Jushi is looking juicy!&nbsp;","text":"Jushi is looking juicy!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839065348","repostId":"2159210869","repostType":4,"isVote":1,"tweetType":1,"viewCount":2651,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897310360,"gmtCreate":1628879977050,"gmtModify":1676529883939,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Nice stock to consider&nbsp;","listText":"Nice stock to consider&nbsp;","text":"Nice stock to consider","images":[{"img":"https://static.tigerbbs.com/e3e7f479c4e6b1e4f0c2f5d4aa45c167","width":"750","height":"2326"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/897310360","isVote":1,"tweetType":1,"viewCount":2596,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":892098901,"gmtCreate":1628608810503,"gmtModify":1676529797101,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>like and comment&nbsp;","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>like and comment&nbsp;","text":"$Apple(AAPL)$like and comment","images":[{"img":"https://static.tigerbbs.com/23179b079b92d3ca411908da43a7ccfe","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/892098901","isVote":1,"tweetType":1,"viewCount":2296,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":892091564,"gmtCreate":1628608778258,"gmtModify":1676529797118,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[{"img":"https://static.tigerbbs.com/7f70b3afdfce471c0bfb5bc564bc36eb","width":"750","height":"2217"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/892091564","isVote":1,"tweetType":1,"viewCount":2313,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":891314881,"gmtCreate":1628333347343,"gmtModify":1703505166534,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OGI\">$ORGANIGRAM HOLD(OGI)$</a>To consider for long term medical cannabis play","listText":"<a href=\"https://laohu8.com/S/OGI\">$ORGANIGRAM HOLD(OGI)$</a>To consider for long term medical cannabis play","text":"$ORGANIGRAM HOLD(OGI)$To consider for long term medical cannabis play","images":[{"img":"https://static.tigerbbs.com/99605973d44ebb4b7b1373ebfbbcc8d6","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/891314881","isVote":1,"tweetType":1,"viewCount":2532,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":891314197,"gmtCreate":1628333296719,"gmtModify":1703505167191,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Can consider playing this&nbsp;","listText":"Can consider playing this&nbsp;","text":"Can consider playing this","images":[{"img":"https://static.tigerbbs.com/782fd7cc0dbe719e6682dadeea8f31d7","width":"750","height":"2034"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/891314197","isVote":1,"tweetType":1,"viewCount":2549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":893923519,"gmtCreate":1628230995931,"gmtModify":1703503612251,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Perfect location","listText":"Perfect location","text":"Perfect location","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/893923519","repostId":"1111773166","repostType":4,"isVote":1,"tweetType":1,"viewCount":2798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893920812,"gmtCreate":1628230797336,"gmtModify":1703503609267,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/42C.SI\">$IX BIOPHARMA LTD.(42C.SI)$</a>Soon it will change around&nbsp;","listText":"<a href=\"https://laohu8.com/S/42C.SI\">$IX BIOPHARMA LTD.(42C.SI)$</a>Soon it will change around&nbsp;","text":"$IX BIOPHARMA LTD.(42C.SI)$Soon it will change around","images":[{"img":"https://static.tigerbbs.com/f582ab96c3b605ba736a3d8e0f38f168","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/893920812","isVote":1,"tweetType":1,"viewCount":3379,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":893964450,"gmtCreate":1628230639070,"gmtModify":1703503606798,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Bought into this after researching UoBKH prospectus","listText":"Bought into this after researching UoBKH prospectus","text":"Bought into this after researching UoBKH prospectus","images":[{"img":"https://static.tigerbbs.com/000b31b369ef1aece8d0188eb786b071","width":"750","height":"1744"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/893964450","isVote":1,"tweetType":1,"viewCount":760,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":899606024,"gmtCreate":1628176144368,"gmtModify":1703502678077,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Psilocybin play anyone?","listText":"Psilocybin play anyone?","text":"Psilocybin play anyone?","images":[{"img":"https://static.tigerbbs.com/f0a3ba3a084c24d9121b3b41f1fe37ab","width":"750","height":"2034"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899606024","isVote":1,"tweetType":1,"viewCount":672,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":899874679,"gmtCreate":1628175879391,"gmtModify":1703502668519,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899874679","repostId":"1173170520","repostType":4,"isVote":1,"tweetType":1,"viewCount":1000,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804097553,"gmtCreate":1627911389972,"gmtModify":1703497703918,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Buying SQ is a good idea now with plans to do open international flights&nbsp;","listText":"Buying SQ is a good idea now with plans to do open international flights&nbsp;","text":"Buying SQ is a good idea now with plans to do open international flights","images":[{"img":"https://static.tigerbbs.com/d15c987e3f58a1513c34332b10385a41","width":"750","height":"1744"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/804097553","isVote":1,"tweetType":1,"viewCount":1249,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":804098894,"gmtCreate":1627911285518,"gmtModify":1703497697899,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"To look out for this&nbsp;","listText":"To look out for this&nbsp;","text":"To look out for this","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/804098894","repostId":"1191057621","repostType":4,"repost":{"id":"1191057621","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627905199,"share":"https://ttm.financial/m/news/1191057621?lang=en_US&edition=fundamental","pubTime":"2021-08-02 19:53","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1191057621","media":"Tiger Newspress","summary":"Futures rise amid earnings optimism; Dollar dips.\nSquare, Moderna, First Solar and more made the big","content":"<ul>\n <li>Futures rise amid earnings optimism; Dollar dips.</li>\n <li>Square, Moderna, First Solar and more made the biggest moves in the premarket.</li>\n <li>Treasuries steady; crude oil declines on China outlook.</li>\n</ul>\n<p>(August&nbsp;2)&nbsp;U.S. index futures gained along with European stocks as upbeat earnings and a surge in corporatedealmakinglifted sentiment, offsetting lingering concerns over China’s regulatory crackdown and the spread of the delta virus variant.</p>\n<p>U.S. S&amp;P 500 E-minis were up 19.5 points, or 0.44%, at 07:52 a.m. ET. Dow E-minis gained 118 points, or 0.34%, while Nasdaq 100 E-minis rose 66.75 points, or 0.45%.</p>\n<p><img src=\"https://static.tigerbbs.com/ffb408f47638770562209367ca7ab1f1\" tg-width=\"1242\" tg-height=\"517\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>1)&nbsp;Square(SQ)</b> – The digital payments company agreed to buy Australia’s Afterpayfor about $29 billion in stock, representing a roughly 30% premium for Afterpay shareholders. Square shares fell 4.8% in the premarket, but news of the deal boosted shares of U.S.-based payment companyAffirm(AFRM) by 8.2%.</p>\n<p><b>2)&nbsp;Zoom Video(ZM) </b>– The video conferencing companyagreed to pay $85 millionto settle a lawsuit accusing it violated the privacy rights of users. It also agreed to beef up its security practices to prevent so-called “Zoombombing,” where hackers disrupted Zoom meetings.</p>\n<p><b>3)&nbsp;General Electric(GE)</b> – GE has completed its previously announced one-for-eight reverse stock split and will begin trading on a post-split basis today.</p>\n<p><b>4)&nbsp;Moderna(MRNA),Pfizer(PFE),BioNTech(BNTX)</b> – Moderna and Pfizer both raised prices for their Covid-19 vaccines in their latest supply contracts, according to the Financial Times. Additionally, The Wall Street Journal reported that the Food and Drug Administration is under pressure to give both vaccines full approval and that this could happen within the next month for Pfizer and partner BioNTech. Moderna rose 2.5% in the premarket, Pfizer gained 1%, while BioNTech surged 5.1%.</p>\n<p><b>5)&nbsp;Foot Locker(FL)</b> – The athletic footwear and apparel retailer announced a deal to buy California-based shoe store chain WSS for $750 million and Japan-based streetwear brand Atmos for $360 million.</p>\n<p><b>6)&nbsp;Uber Technologies(UBER)</b> – Shares of Uber gained 1.1% in premarket trading after Gordon Haskett Research Advisors initiated coverage with a “buy” rating. Haskett called Uber a company that is continually engraining itself in the everyday lives of consumers through its ride-hailing and food delivery services.</p>\n<p><b>7)&nbsp;Capri Holdings(CPRI)</b> – Capri rose 1.2% in the premarket following an upgrade to “buy” from “neutral” at MKM Partners, which noted a string of better than expected quarters for the company behind brands like Michael Kors and Versace. MKM also cited an overall improvement in the luxury goods sector.</p>\n<p><b>8)&nbsp;Discovery(DISCA)</b> – Discovery is in informal talks about a potential bid for British state-owned broadcaster Channel 4, according to Britain’s Telegraph newspaper.</p>\n<p><b>9)&nbsp;Robinhood(HOOD)</b> – More than 300,000 users of the stock trading app bought shares in Robinhood’s initial public offering last week, according to The Wall Street Journal. That represents about 1.3% of the company’s funded account base. Robinhood added 1.5% in premarket trading.</p>\n<p><b>10)&nbsp;Parker-Hannifin(PH)</b> – The maker of motion control technology and other industrial products is buying British rival Meggitt for about $8.8 billion in cash. Parker-Hannifin shares fell 2.2% in premarket action.</p>\n<p><b>11)&nbsp;Li Auto(LI)</b> – The China-based electric vehicle maker delivered 8,589 vehicles in July, an increase of 125% compared to July 2020. Li’s U.S.-based shares surged 4.3% in the premarket.</p>\n<p><b>12)&nbsp;First Solar(FSLR)</b> – The solar power systems maker’s shares gained 2.9% in premarket trading after Susquehanna Financial upgraded the stock to “positive” from “neutral,” based on upbeat management comments on solar module demand and pricing.</p>\n<p><b>In FX,</b>a relatively sedate start to the new week and month, but the Dollar has lost some recovery momentum and is moderately softer vs high beta and cyclical counterparts amidst a general improvement in risk sentiment. Hence, the index slipped back beneath 92.000 within a 92.174-91.962 band before finding a base and awaiting the final US Markit manufacturing PMI, construction spending and ISM in particular for the survey breakdown and first jobs proxy for Friday’s NFP.</p>\n<ul>\n <li>AUD/NZD/EUR/GBP - The Aussie and Kiwi have both regained some composure to pare overnight losses incurred on the back of further COVID restrictions, a Chinese manufacturing PMI miss, technical and cross-related factors. However, Aud/Usd remains heavy above 0.7350 and unlikely to trouble hefty option expiry interest at the 0.7400 strike (1.2 bn) ahead of the RBA tomorrow given expectations that the ongoing pandemic outbreaks could well force the Bank to backtrack on QE tapering plans. Meanwhile, Nzd/Usd is still rotating around the 21 DMA that comes in at 0.6979 today having failed to retain grasp of the 0.7000 handle, and the Euro is back below 1.1900 where 1.4 bn option expiries reside in wake of broadly softer than expected Eurozone manufacturing PMIs, bar Germany’s upgrade. Conversely, Cable is back over 1.3900 and Eur/Gbp is holding under 0.8550 following an unrevised final UK manufacturing PMI in advance of Thursday’s BoE.</li>\n <li>CAD/JPY/CHF - All very narrowly divergent vs the Greenback, and the Loonie holding up well in the face of weakness in WTI crude circa 1.2470, while the Yen is meandering from 109.60-77 in the run up to Tokyo inflation data on Tuesday and the Franc is straddling 0.9055 after in line Swiss CPI, a slowdown in retail sales vs pick up in the manufacturing PMI and weekly sight deposits showing just a small rise on domestic bank balances.</li>\n <li>SCANDI/EM - Contrasting manufacturing PMIs from Sweden and Norway, as the former dipped and latter gathered pace, but the Sek is straddling 10.2100 against the Eur with assistance from the aforementioned pick-up in overall risk appetite, while the Nok wanes within a 10.4910-10.4530 range due to a pull-back in Brent prices from Usd 75+/brl towards Usd 74.00.</li>\n</ul>\n<p><b>In commodities,</b>WTI and Brent have commenced the week on the backfoot, with the benchmarks lower by USD 1.00/bbl on the session. Such pressure comes in spite of the generally modestly constructive risk tone in a quiet European session with final PMIs not moving the dial much; with attention more on the weeks macro themes as outlined above. In crude specifics, updates have been very sparse throughout the session and as such the complex is more focus on COVID-19 related dynamics. With the demand-side of the equation torn between the ongoing case increases in Tokyo, among other areas, but on the flip-side supported by a push from top UK Cabinet Officials for an easing of travel restrictions and more broadly as NIH’s Fauci now does not believe the US is likely to return to lockdowns. Elsewhere, attention is on the geopolitical front and specifically last week’s attack on a ship off the Oman coast on which the US Secretary of State is confident that Iran is behind this attack. Moving to metals, spot gold and silver are modestly pressured with not too much read across from a choppy USD as we stand and likely on the back of the aforementioned broader risk tone; for reference, the yellow metal still holds the USD 1800/oz mark. Separately, much of the mornings focus is on copper where BHPs Escondida, Chile facility is facing strike action after the union rejected BHPs final labour offer. As such, Government-mediated discussions will last for 5-10 days and if the status quo is maintained and there is no breakthrough then strike action will formally commence. Given the uncertainty, LME Copper is supported on the session albeit still well off the pivotal USD 10k/t mark vs the current high USD 9799/t.</p>\n<p><b>US Event Calendar</b></p>\n<ul>\n <li>9:45am: July Markit US Manufacturing PMI, est. 63.1, prior 63.1</li>\n <li>10am: June Construction Spending MoM, est. 0.5%, prior -0.3%</li>\n <li>10am: July ISM Manufacturing, est. 60.9, prior 60.6</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-02 19:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Futures rise amid earnings optimism; Dollar dips.</li>\n <li>Square, Moderna, First Solar and more made the biggest moves in the premarket.</li>\n <li>Treasuries steady; crude oil declines on China outlook.</li>\n</ul>\n<p>(August&nbsp;2)&nbsp;U.S. index futures gained along with European stocks as upbeat earnings and a surge in corporatedealmakinglifted sentiment, offsetting lingering concerns over China’s regulatory crackdown and the spread of the delta virus variant.</p>\n<p>U.S. S&amp;P 500 E-minis were up 19.5 points, or 0.44%, at 07:52 a.m. ET. Dow E-minis gained 118 points, or 0.34%, while Nasdaq 100 E-minis rose 66.75 points, or 0.45%.</p>\n<p><img src=\"https://static.tigerbbs.com/ffb408f47638770562209367ca7ab1f1\" tg-width=\"1242\" tg-height=\"517\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>1)&nbsp;Square(SQ)</b> – The digital payments company agreed to buy Australia’s Afterpayfor about $29 billion in stock, representing a roughly 30% premium for Afterpay shareholders. Square shares fell 4.8% in the premarket, but news of the deal boosted shares of U.S.-based payment companyAffirm(AFRM) by 8.2%.</p>\n<p><b>2)&nbsp;Zoom Video(ZM) </b>– The video conferencing companyagreed to pay $85 millionto settle a lawsuit accusing it violated the privacy rights of users. It also agreed to beef up its security practices to prevent so-called “Zoombombing,” where hackers disrupted Zoom meetings.</p>\n<p><b>3)&nbsp;General Electric(GE)</b> – GE has completed its previously announced one-for-eight reverse stock split and will begin trading on a post-split basis today.</p>\n<p><b>4)&nbsp;Moderna(MRNA),Pfizer(PFE),BioNTech(BNTX)</b> – Moderna and Pfizer both raised prices for their Covid-19 vaccines in their latest supply contracts, according to the Financial Times. Additionally, The Wall Street Journal reported that the Food and Drug Administration is under pressure to give both vaccines full approval and that this could happen within the next month for Pfizer and partner BioNTech. Moderna rose 2.5% in the premarket, Pfizer gained 1%, while BioNTech surged 5.1%.</p>\n<p><b>5)&nbsp;Foot Locker(FL)</b> – The athletic footwear and apparel retailer announced a deal to buy California-based shoe store chain WSS for $750 million and Japan-based streetwear brand Atmos for $360 million.</p>\n<p><b>6)&nbsp;Uber Technologies(UBER)</b> – Shares of Uber gained 1.1% in premarket trading after Gordon Haskett Research Advisors initiated coverage with a “buy” rating. Haskett called Uber a company that is continually engraining itself in the everyday lives of consumers through its ride-hailing and food delivery services.</p>\n<p><b>7)&nbsp;Capri Holdings(CPRI)</b> – Capri rose 1.2% in the premarket following an upgrade to “buy” from “neutral” at MKM Partners, which noted a string of better than expected quarters for the company behind brands like Michael Kors and Versace. MKM also cited an overall improvement in the luxury goods sector.</p>\n<p><b>8)&nbsp;Discovery(DISCA)</b> – Discovery is in informal talks about a potential bid for British state-owned broadcaster Channel 4, according to Britain’s Telegraph newspaper.</p>\n<p><b>9)&nbsp;Robinhood(HOOD)</b> – More than 300,000 users of the stock trading app bought shares in Robinhood’s initial public offering last week, according to The Wall Street Journal. That represents about 1.3% of the company’s funded account base. Robinhood added 1.5% in premarket trading.</p>\n<p><b>10)&nbsp;Parker-Hannifin(PH)</b> – The maker of motion control technology and other industrial products is buying British rival Meggitt for about $8.8 billion in cash. Parker-Hannifin shares fell 2.2% in premarket action.</p>\n<p><b>11)&nbsp;Li Auto(LI)</b> – The China-based electric vehicle maker delivered 8,589 vehicles in July, an increase of 125% compared to July 2020. Li’s U.S.-based shares surged 4.3% in the premarket.</p>\n<p><b>12)&nbsp;First Solar(FSLR)</b> – The solar power systems maker’s shares gained 2.9% in premarket trading after Susquehanna Financial upgraded the stock to “positive” from “neutral,” based on upbeat management comments on solar module demand and pricing.</p>\n<p><b>In FX,</b>a relatively sedate start to the new week and month, but the Dollar has lost some recovery momentum and is moderately softer vs high beta and cyclical counterparts amidst a general improvement in risk sentiment. Hence, the index slipped back beneath 92.000 within a 92.174-91.962 band before finding a base and awaiting the final US Markit manufacturing PMI, construction spending and ISM in particular for the survey breakdown and first jobs proxy for Friday’s NFP.</p>\n<ul>\n <li>AUD/NZD/EUR/GBP - The Aussie and Kiwi have both regained some composure to pare overnight losses incurred on the back of further COVID restrictions, a Chinese manufacturing PMI miss, technical and cross-related factors. However, Aud/Usd remains heavy above 0.7350 and unlikely to trouble hefty option expiry interest at the 0.7400 strike (1.2 bn) ahead of the RBA tomorrow given expectations that the ongoing pandemic outbreaks could well force the Bank to backtrack on QE tapering plans. Meanwhile, Nzd/Usd is still rotating around the 21 DMA that comes in at 0.6979 today having failed to retain grasp of the 0.7000 handle, and the Euro is back below 1.1900 where 1.4 bn option expiries reside in wake of broadly softer than expected Eurozone manufacturing PMIs, bar Germany’s upgrade. Conversely, Cable is back over 1.3900 and Eur/Gbp is holding under 0.8550 following an unrevised final UK manufacturing PMI in advance of Thursday’s BoE.</li>\n <li>CAD/JPY/CHF - All very narrowly divergent vs the Greenback, and the Loonie holding up well in the face of weakness in WTI crude circa 1.2470, while the Yen is meandering from 109.60-77 in the run up to Tokyo inflation data on Tuesday and the Franc is straddling 0.9055 after in line Swiss CPI, a slowdown in retail sales vs pick up in the manufacturing PMI and weekly sight deposits showing just a small rise on domestic bank balances.</li>\n <li>SCANDI/EM - Contrasting manufacturing PMIs from Sweden and Norway, as the former dipped and latter gathered pace, but the Sek is straddling 10.2100 against the Eur with assistance from the aforementioned pick-up in overall risk appetite, while the Nok wanes within a 10.4910-10.4530 range due to a pull-back in Brent prices from Usd 75+/brl towards Usd 74.00.</li>\n</ul>\n<p><b>In commodities,</b>WTI and Brent have commenced the week on the backfoot, with the benchmarks lower by USD 1.00/bbl on the session. Such pressure comes in spite of the generally modestly constructive risk tone in a quiet European session with final PMIs not moving the dial much; with attention more on the weeks macro themes as outlined above. In crude specifics, updates have been very sparse throughout the session and as such the complex is more focus on COVID-19 related dynamics. With the demand-side of the equation torn between the ongoing case increases in Tokyo, among other areas, but on the flip-side supported by a push from top UK Cabinet Officials for an easing of travel restrictions and more broadly as NIH’s Fauci now does not believe the US is likely to return to lockdowns. Elsewhere, attention is on the geopolitical front and specifically last week’s attack on a ship off the Oman coast on which the US Secretary of State is confident that Iran is behind this attack. Moving to metals, spot gold and silver are modestly pressured with not too much read across from a choppy USD as we stand and likely on the back of the aforementioned broader risk tone; for reference, the yellow metal still holds the USD 1800/oz mark. Separately, much of the mornings focus is on copper where BHPs Escondida, Chile facility is facing strike action after the union rejected BHPs final labour offer. As such, Government-mediated discussions will last for 5-10 days and if the status quo is maintained and there is no breakthrough then strike action will formally commence. Given the uncertainty, LME Copper is supported on the session albeit still well off the pivotal USD 10k/t mark vs the current high USD 9799/t.</p>\n<p><b>US Event Calendar</b></p>\n<ul>\n <li>9:45am: July Markit US Manufacturing PMI, est. 63.1, prior 63.1</li>\n <li>10am: June Construction Spending MoM, est. 0.5%, prior -0.3%</li>\n <li>10am: July ISM Manufacturing, est. 60.9, prior 60.6</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","FSLR":"第一太阳能","PH":"汉尼汾","MRNA":"Moderna, Inc.","GE":"GE航空航天","LI":"理想汽车","SPY":"标普500ETF","PFE":"辉瑞","CPRI":"Capri Holdings Ltd","ZM":"Zoom",".IXIC":"NASDAQ Composite","DISCA":"探索传播","UBER":"优步",".SPX":"S&P 500 Index",".DJI":"道琼斯","HOOD":"Robinhood"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191057621","content_text":"Futures rise amid earnings optimism; Dollar dips.\nSquare, Moderna, First Solar and more made the biggest moves in the premarket.\nTreasuries steady; crude oil declines on China outlook.\n\n(August 2) U.S. index futures gained along with European stocks as upbeat earnings and a surge in corporatedealmakinglifted sentiment, offsetting lingering concerns over China’s regulatory crackdown and the spread of the delta virus variant.\nU.S. S&P 500 E-minis were up 19.5 points, or 0.44%, at 07:52 a.m. ET. Dow E-minis gained 118 points, or 0.34%, while Nasdaq 100 E-minis rose 66.75 points, or 0.45%.\n\nStocks making the biggest moves in the premarket:\n1) Square(SQ) – The digital payments company agreed to buy Australia’s Afterpayfor about $29 billion in stock, representing a roughly 30% premium for Afterpay shareholders. Square shares fell 4.8% in the premarket, but news of the deal boosted shares of U.S.-based payment companyAffirm(AFRM) by 8.2%.\n2) Zoom Video(ZM) – The video conferencing companyagreed to pay $85 millionto settle a lawsuit accusing it violated the privacy rights of users. It also agreed to beef up its security practices to prevent so-called “Zoombombing,” where hackers disrupted Zoom meetings.\n3) General Electric(GE) – GE has completed its previously announced one-for-eight reverse stock split and will begin trading on a post-split basis today.\n4) Moderna(MRNA),Pfizer(PFE),BioNTech(BNTX) – Moderna and Pfizer both raised prices for their Covid-19 vaccines in their latest supply contracts, according to the Financial Times. Additionally, The Wall Street Journal reported that the Food and Drug Administration is under pressure to give both vaccines full approval and that this could happen within the next month for Pfizer and partner BioNTech. Moderna rose 2.5% in the premarket, Pfizer gained 1%, while BioNTech surged 5.1%.\n5) Foot Locker(FL) – The athletic footwear and apparel retailer announced a deal to buy California-based shoe store chain WSS for $750 million and Japan-based streetwear brand Atmos for $360 million.\n6) Uber Technologies(UBER) – Shares of Uber gained 1.1% in premarket trading after Gordon Haskett Research Advisors initiated coverage with a “buy” rating. Haskett called Uber a company that is continually engraining itself in the everyday lives of consumers through its ride-hailing and food delivery services.\n7) Capri Holdings(CPRI) – Capri rose 1.2% in the premarket following an upgrade to “buy” from “neutral” at MKM Partners, which noted a string of better than expected quarters for the company behind brands like Michael Kors and Versace. MKM also cited an overall improvement in the luxury goods sector.\n8) Discovery(DISCA) – Discovery is in informal talks about a potential bid for British state-owned broadcaster Channel 4, according to Britain’s Telegraph newspaper.\n9) Robinhood(HOOD) – More than 300,000 users of the stock trading app bought shares in Robinhood’s initial public offering last week, according to The Wall Street Journal. That represents about 1.3% of the company’s funded account base. Robinhood added 1.5% in premarket trading.\n10) Parker-Hannifin(PH) – The maker of motion control technology and other industrial products is buying British rival Meggitt for about $8.8 billion in cash. Parker-Hannifin shares fell 2.2% in premarket action.\n11) Li Auto(LI) – The China-based electric vehicle maker delivered 8,589 vehicles in July, an increase of 125% compared to July 2020. Li’s U.S.-based shares surged 4.3% in the premarket.\n12) First Solar(FSLR) – The solar power systems maker’s shares gained 2.9% in premarket trading after Susquehanna Financial upgraded the stock to “positive” from “neutral,” based on upbeat management comments on solar module demand and pricing.\nIn FX,a relatively sedate start to the new week and month, but the Dollar has lost some recovery momentum and is moderately softer vs high beta and cyclical counterparts amidst a general improvement in risk sentiment. Hence, the index slipped back beneath 92.000 within a 92.174-91.962 band before finding a base and awaiting the final US Markit manufacturing PMI, construction spending and ISM in particular for the survey breakdown and first jobs proxy for Friday’s NFP.\n\nAUD/NZD/EUR/GBP - The Aussie and Kiwi have both regained some composure to pare overnight losses incurred on the back of further COVID restrictions, a Chinese manufacturing PMI miss, technical and cross-related factors. However, Aud/Usd remains heavy above 0.7350 and unlikely to trouble hefty option expiry interest at the 0.7400 strike (1.2 bn) ahead of the RBA tomorrow given expectations that the ongoing pandemic outbreaks could well force the Bank to backtrack on QE tapering plans. Meanwhile, Nzd/Usd is still rotating around the 21 DMA that comes in at 0.6979 today having failed to retain grasp of the 0.7000 handle, and the Euro is back below 1.1900 where 1.4 bn option expiries reside in wake of broadly softer than expected Eurozone manufacturing PMIs, bar Germany’s upgrade. Conversely, Cable is back over 1.3900 and Eur/Gbp is holding under 0.8550 following an unrevised final UK manufacturing PMI in advance of Thursday’s BoE.\nCAD/JPY/CHF - All very narrowly divergent vs the Greenback, and the Loonie holding up well in the face of weakness in WTI crude circa 1.2470, while the Yen is meandering from 109.60-77 in the run up to Tokyo inflation data on Tuesday and the Franc is straddling 0.9055 after in line Swiss CPI, a slowdown in retail sales vs pick up in the manufacturing PMI and weekly sight deposits showing just a small rise on domestic bank balances.\nSCANDI/EM - Contrasting manufacturing PMIs from Sweden and Norway, as the former dipped and latter gathered pace, but the Sek is straddling 10.2100 against the Eur with assistance from the aforementioned pick-up in overall risk appetite, while the Nok wanes within a 10.4910-10.4530 range due to a pull-back in Brent prices from Usd 75+/brl towards Usd 74.00.\n\nIn commodities,WTI and Brent have commenced the week on the backfoot, with the benchmarks lower by USD 1.00/bbl on the session. Such pressure comes in spite of the generally modestly constructive risk tone in a quiet European session with final PMIs not moving the dial much; with attention more on the weeks macro themes as outlined above. In crude specifics, updates have been very sparse throughout the session and as such the complex is more focus on COVID-19 related dynamics. With the demand-side of the equation torn between the ongoing case increases in Tokyo, among other areas, but on the flip-side supported by a push from top UK Cabinet Officials for an easing of travel restrictions and more broadly as NIH’s Fauci now does not believe the US is likely to return to lockdowns. Elsewhere, attention is on the geopolitical front and specifically last week’s attack on a ship off the Oman coast on which the US Secretary of State is confident that Iran is behind this attack. Moving to metals, spot gold and silver are modestly pressured with not too much read across from a choppy USD as we stand and likely on the back of the aforementioned broader risk tone; for reference, the yellow metal still holds the USD 1800/oz mark. Separately, much of the mornings focus is on copper where BHPs Escondida, Chile facility is facing strike action after the union rejected BHPs final labour offer. As such, Government-mediated discussions will last for 5-10 days and if the status quo is maintained and there is no breakthrough then strike action will formally commence. Given the uncertainty, LME Copper is supported on the session albeit still well off the pivotal USD 10k/t mark vs the current high USD 9799/t.\nUS Event Calendar\n\n9:45am: July Markit US Manufacturing PMI, est. 63.1, prior 63.1\n10am: June Construction Spending MoM, est. 0.5%, prior -0.3%\n10am: July ISM Manufacturing, est. 60.9, prior 60.6","news_type":1,"symbols_score_info":{"FSLR":0.9,"SQ":0.9,"BNTX":0.9,".DJI":0.9,"DISCA":0.9,"MRNA":0.9,"UBER":0.9,"GE":0.9,"LI":0.9,"PFE":0.9,"HOOD":0.9,"FL":0.9,".SPX":0.9,"PH":0.9,"CPRI":0.9,"SPY":0.9,"ZM":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":1091,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804093651,"gmtCreate":1627911240373,"gmtModify":1703497694583,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OGI\">$ORGANIGRAM HOLD(OGI)$</a>Looking into medicinal cannabis&nbsp;","listText":"<a href=\"https://laohu8.com/S/OGI\">$ORGANIGRAM HOLD(OGI)$</a>Looking into medicinal cannabis&nbsp;","text":"$ORGANIGRAM HOLD(OGI)$Looking into medicinal cannabis","images":[{"img":"https://static.tigerbbs.com/6b83510f07a1469c90658c4e1796e150","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/804093651","isVote":1,"tweetType":1,"viewCount":1137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":802950921,"gmtCreate":1627709509063,"gmtModify":1703495083620,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Huge growth potential esp in the medicinal cannabis space. One to go long with&nbsp;","listText":"Huge growth potential esp in the medicinal cannabis space. One to go long with&nbsp;","text":"Huge growth potential esp in the medicinal cannabis space. One to go long with","images":[{"img":"https://static.tigerbbs.com/8a586189aeff973a47bbb82c4b0bb7e8","width":"750","height":"1744"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802950921","isVote":1,"tweetType":1,"viewCount":926,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":802927435,"gmtCreate":1627709442327,"gmtModify":1703495082640,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/42C.SI\">$IX BIOPHARMA LTD.(42C.SI)$</a>Looking at this undervalued sg stock","listText":"<a href=\"https://laohu8.com/S/42C.SI\">$IX BIOPHARMA LTD.(42C.SI)$</a>Looking at this undervalued sg stock","text":"$IX BIOPHARMA LTD.(42C.SI)$Looking at this undervalued sg stock","images":[{"img":"https://static.tigerbbs.com/f582ab96c3b605ba736a3d8e0f38f168","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/802927435","isVote":1,"tweetType":1,"viewCount":919,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":802926147,"gmtCreate":1627708893389,"gmtModify":1703495077106,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Check out undervalue SG stocks&nbsp;","listText":"Check out undervalue SG stocks&nbsp;","text":"Check out undervalue SG stocks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802926147","repostId":"1167653033","repostType":4,"repost":{"id":"1167653033","kind":"news","pubTimestamp":1627706886,"share":"https://ttm.financial/m/news/1167653033?lang=en_US&edition=fundamental","pubTime":"2021-07-31 12:48","market":"sg","language":"en","title":"SGD to weaken to $1.35/USD amidst COVID-19 woes: Fitch","url":"https://stock-news.laohu8.com/highlight/detail?id=1167653033","media":"Singapore Business","summary":"The Singapore dollar (SGD) is expected to weaken to $1.35 versus the US dollar (USD) for 2021, accor","content":"<p>The Singapore dollar (SGD) is expected to weaken to $1.35 versus the US dollar (USD) for 2021, according to Fitch Solutions, to weaken further to $1.36 in 2022.</p>\n<p>This is a downgrade from its previous forecast of $1.33 against the greenback for 2021 and $1.32 in 2022.</p>\n<p>“The SGD has weakened in line with most other Asian currencies after the Fed’s hawkish surprise on June 16, and will likely trade in a weaker range between $1.35 per USD and $1.38 per USD for the remainder of 2021 and likely in 2022 as well,” Fitch said.</p>\n<p>This is due to the risk-off sentiment sparked by the resurgence of COVID-19 infections across Asia, including the key economies of Indonesia, Malaysia, and Thailand.</p>\n<p>The SGD&nbsp;also breached the key support level of $1.35 per USD on 8 July and has weakened since. The last time Singapore breached this level was in July 2018, during the initial phases of the US-China trade war.</p>\n<p>“However, any weakness in the SGD should be capped by the economy being in a much more resilient position than other Asian markets, due to the fast progress in vaccinating the population,” it added. “This puts Singapore in a much more resilient position compared to most other Asian economies and the SGD could benefit from some degree of safe-haven flows from elsewhere in the region as the year progresses, limiting prospects for further depreciation beyond our identified trading range.”</p>\n<p>For the long term, Fitch expects a strong recovery in exports to support the currency in 2022, but balanced by the risk of a potentially more hawkish US Fed if above-2% target inflation persists.</p>\n<p>Fitch Solutions identified as a key risk the possibility of a COVID-19 variant that can bypass existing vaccines, which could force Singapore to implement further lockdowns.</p>","source":"lsy1618986048053","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SGD to weaken to $1.35/USD amidst COVID-19 woes: Fitch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSGD to weaken to $1.35/USD amidst COVID-19 woes: Fitch\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-31 12:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://sbr.com.sg/economy/in-focus/sgd-weaken-135usd-amidst-covid-19-woes-fitch><strong>Singapore Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Singapore dollar (SGD) is expected to weaken to $1.35 versus the US dollar (USD) for 2021, according to Fitch Solutions, to weaken further to $1.36 in 2022.\nThis is a downgrade from its previous ...</p>\n\n<a href=\"https://sbr.com.sg/economy/in-focus/sgd-weaken-135usd-amidst-covid-19-woes-fitch\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://sbr.com.sg/economy/in-focus/sgd-weaken-135usd-amidst-covid-19-woes-fitch","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167653033","content_text":"The Singapore dollar (SGD) is expected to weaken to $1.35 versus the US dollar (USD) for 2021, according to Fitch Solutions, to weaken further to $1.36 in 2022.\nThis is a downgrade from its previous forecast of $1.33 against the greenback for 2021 and $1.32 in 2022.\n“The SGD has weakened in line with most other Asian currencies after the Fed’s hawkish surprise on June 16, and will likely trade in a weaker range between $1.35 per USD and $1.38 per USD for the remainder of 2021 and likely in 2022 as well,” Fitch said.\nThis is due to the risk-off sentiment sparked by the resurgence of COVID-19 infections across Asia, including the key economies of Indonesia, Malaysia, and Thailand.\nThe SGD also breached the key support level of $1.35 per USD on 8 July and has weakened since. The last time Singapore breached this level was in July 2018, during the initial phases of the US-China trade war.\n“However, any weakness in the SGD should be capped by the economy being in a much more resilient position than other Asian markets, due to the fast progress in vaccinating the population,” it added. “This puts Singapore in a much more resilient position compared to most other Asian economies and the SGD could benefit from some degree of safe-haven flows from elsewhere in the region as the year progresses, limiting prospects for further depreciation beyond our identified trading range.”\nFor the long term, Fitch expects a strong recovery in exports to support the currency in 2022, but balanced by the risk of a potentially more hawkish US Fed if above-2% target inflation persists.\nFitch Solutions identified as a key risk the possibility of a COVID-19 variant that can bypass existing vaccines, which could force Singapore to implement further lockdowns.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":720,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806202452,"gmtCreate":1627655976976,"gmtModify":1703494282326,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Pivot is required&nbsp;","listText":"Pivot is required&nbsp;","text":"Pivot is required","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/806202452","repostId":"1157771608","repostType":4,"isVote":1,"tweetType":1,"viewCount":1103,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":806203633,"gmtCreate":1627655858822,"gmtModify":1703494276067,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Same issues with all other streaming channels, wonder how Netflix can make rights exclusive like they do in cinemas&nbsp;","listText":"Same issues with all other streaming channels, wonder how Netflix can make rights exclusive like they do in cinemas&nbsp;","text":"Same issues with all other streaming channels, wonder how Netflix can make rights exclusive like they do in cinemas","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/806203633","repostId":"2155015802","repostType":4,"isVote":1,"tweetType":1,"viewCount":744,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806208841,"gmtCreate":1627655912283,"gmtModify":1703494278869,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Is it really possible?","listText":"Is it really possible?","text":"Is it really possible?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/806208841","repostId":"1135197909","repostType":4,"repost":{"id":"1135197909","kind":"news","pubTimestamp":1627655217,"share":"https://ttm.financial/m/news/1135197909?lang=en_US&edition=fundamental","pubTime":"2021-07-30 22:26","market":"us","language":"en","title":"Beyond Meat: This Stock Is A Really Raw Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1135197909","media":"seekingalpha","summary":"Summary\n\nShares of Beyond Meat have crumbled more than 40% from highs.\nThe company has been plagued ","content":"<p><b>Summary</b></p>\n<ul>\n <li>Shares of Beyond Meat have crumbled more than 40% from highs.</li>\n <li>The company has been plagued by a number of issues, including slowing growth and a decaying margin profile.</li>\n <li>Retail velocity is declining, suggesting that Beyond Meat's pandemic arguments of limited in-stocks have faded.</li>\n <li>The stock remains expensive against long-term profit expectations.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b94bb6c8b249f2376027245ea44295c3\" tg-width=\"1536\" tg-height=\"1024\" width=\"100%\" height=\"auto\"><span>Drew Angerer/Getty Images News</span></p>\n<p>These days, the market certainly has no shortage of expensive growth stocks that have very little substance. One stock that I think is at particular risk of crumbling further is Beyond Meat (BYND), one of the first purveyors of the faux-meat trend and one of the most recognizable brands in the space.</p>\n<p>Despite the growing appeal of plant-based meats, I continue to see huge fundamental flaws in this stock. The market seems to agree, as Beyond Meat shares have slid by roughly half relative to all-time highs around ~$200 notched last October.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9414d1f0d7b86d62d6febcd8fcfae596\" tg-width=\"635\" tg-height=\"417\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p>In my view, Beyond Meat shares have even more downside left. I continue to cite that there's a \"story\" risk to Beyond Meat: plant-based meats are popular now, but are they a passing dietary fad? The list of diet fads is a long one, ranging from keto diets and paleo diets to complete-nutrient drinks like Huel. While Beyond Meat may find itself a core customer base, I view the category's growth to be limited especially with concerns that plant-based meats are unhealthy from a sodium angle.</p>\n<p>Yet there are shorter-term risks here, too. In particular, investors should be aware that Beyond Meat's growth and demand indicators have weakened in recent quarters. Profit margin slippage is another big concern, especially when the stock is still trading so expensively as a multiple of outer-year profits.</p>\n<p>The bottom line here: Beyond Meat is a spoiling stock, and I think there's little the company can do to get back on the right track.</p>\n<p><b>Slowing growth, decaying velocity</b></p>\n<p>The first thing investors should note is that Beyond Meat has missed Wall Street's expectations for three quarters in a row. It's a small wonder that the stock has landed in investors' \"penalty box\" - in a time when a reliable \"beat and raise\" cadence has become expected for growth stocks, Beyond Meat's earnings gaffes are a huge sore spot.</p>\n<p>In Beyond Meat's most recent quarter (Q1), the company saw relatively tepid 11% y/y growth to $108.2 million in revenue, missing Wall Street's expectations of $113.3 million (+17% y/y) by a huge six-point margin. As shown below, that's an even wider miss than the $2 million gap to expectations in Q4:</p>\n<p>Figure 1. Beyond Meat earnings vs. expectations</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/16650777bf67af7d8aa78be81ba77793\" tg-width=\"640\" tg-height=\"220\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha</span></p>\n<p>At a channel level, in Q1, Beyond Meat its U.S. retail sales grow by 28% y/y, but foodservice sales domestically saw a -26% y/y decline. This is concerning because throughout the March quarter, most areas and restaurants around the country had already lifted lockdown restrictions. We note that the kinds of chain locations that Beyond Meat is typically sold at, from Carls' Jr. to Dunkin' Donuts (DNKN), largely remained open during the pandemic anyway. So Beyond Meat can't really say that lockdowns and the pandemic were to blame for weaker foodservice sales: perhaps the pandemic had ended up ultimately changing consumers' menu preferences toward \"real\" meat, which is often also substantially cheaper than Beyond Meat.</p>\n<p>On the retail side, we note that Beyond Meat's velocity is dropping (a measure of how quickly inventory is selling through on store shelves). Beyond Meat argued that during the pandemic, retail sell-through was constrained by limited supply - but now, what you can see in the chart below is that retail velocity has dramatically dropped over the past four weeks. The company noted that on a year over year basis, velocity is down -18% y/y in Q1.</p>\n<p>Figure 2. Beyond Meat retail velocity</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b0b42961dd5d7be04ea3206e5988ff31\" tg-width=\"640\" tg-height=\"487\" width=\"100%\" height=\"auto\"><span>Source: Beyond Meat Q1 investor presentation</span></p>\n<p>We note as well that Beyond Meat's market share growth in the retail space has slowed as well. The past four weeks only saw Beyond Meat expanding its market share by 127bps, versus 319bps over the past year.</p>\n<p><b>Margin decay</b></p>\n<p>Slowing growth isn't the only troubling indicator for Beyond Meat. The company's gross margin profile, already thin to begin with, is at risk as well. We note that in Beyond Meat's most recent quarter, gross margin slipped to 30.2%, a huge 860bps reduction from 38.8% in the year-ago quarter.</p>\n<p>Figure 3. Beyond Meat margin trends</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/60a3d0d52497e6120e460f59dc453255\" tg-width=\"640\" tg-height=\"403\" width=\"100%\" height=\"auto\"><span>Source: Beyond Meat Q1 investor presentation</span></p>\n<p>The company cited a myriad of reasons behind the decay. The company blamed the decay on rising storage/warehousing and transportation costs, which is similar to what many other consumer products companies are citing. Even more concerning, however, the company has cited rising fixed overhead costs at its production facilities. And perhaps riskiest of all is the fact that Beyond Meat notes that unfavorable product mix and higher trade discounts have also worked to push margins down.<b>In spite of the fact that Beyond Meat leaned in more heavily on trade discounts to grow sales, the company still saw tepid revenue growth and thinning market share gains.</b></p>\n<p>We note as well that Beyond Meat's adjusted EBITDA gains of $13.9 million from last Q1 turned into a -$10.8 million loss in the most recent Q1, indicating a 24-point decay in adjusted EBITDA margins. We have to wonder: is Beyond Meat structurally set up to be a profitable business?</p>\n<p>The company likes to tout the fact that it spends ~8% of its revenue on R&amp;D as a positive signal of the brand's innovation. But the other brands shown on the company's below slide are also innovators. Food brands like Kellogg and Kraft Heinz are constantly coming up with new cereal types and new flavors of their existing foods. Beyond Meat doesn't have a sole claim to innovation in the food space - yet it's spending considerably more than its peers on R&amp;D. When we note the fact that Beyond Meat's gross margin is only ~30% to begin with, spending a further 8% of revenue on R&amp;D is a steep ask.</p>\n<p>Figure 4. Beyond Meat R&amp;D spend</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/be6034dec9a6fb17f07f983fc301eb96\" tg-width=\"640\" tg-height=\"437\" width=\"100%\" height=\"auto\"><span>Source: Beyond Meat Q1 investor presentation</span></p>\n<p><b>Valuation and key takeaways</b></p>\n<p>Analysts aren't really expecting Beyond Meat to generate significant profits until years down the road. As shown in the chart below, the company is only expected to pass breakeven in 2023.</p>\n<p>Figure 5. Beyond Meat earnings estimates</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b43ec61762ea332f9fcc74cabd299bb8\" tg-width=\"640\" tg-height=\"220\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha</span></p>\n<p>And even against 2026 earnings expectations of $5.30 per share, and even after Beyond Meat's correction from all-time highs above $200, the stock's current price at ~$125 sits at a steep&nbsp;<b>23.6x P/E ratio against earnings five years down the line.</b></p>\n<p>With the risks of Beyond Meat's slowing growth and unsteady gross margins, I think the chances of Beyond Meat justifying its current share price (let alone rallying substantially from current levels) are slim.</p>\n<p>Continue to avoid this stock.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beyond Meat: This Stock Is A Really Raw Deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeyond Meat: This Stock Is A Really Raw Deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-30 22:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4443013-beyond-meat-this-stock-is-a-really-raw-deal><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nShares of Beyond Meat have crumbled more than 40% from highs.\nThe company has been plagued by a number of issues, including slowing growth and a decaying margin profile.\nRetail velocity is ...</p>\n\n<a href=\"https://seekingalpha.com/article/4443013-beyond-meat-this-stock-is-a-really-raw-deal\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BYND":"Beyond Meat, Inc."},"source_url":"https://seekingalpha.com/article/4443013-beyond-meat-this-stock-is-a-really-raw-deal","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135197909","content_text":"Summary\n\nShares of Beyond Meat have crumbled more than 40% from highs.\nThe company has been plagued by a number of issues, including slowing growth and a decaying margin profile.\nRetail velocity is declining, suggesting that Beyond Meat's pandemic arguments of limited in-stocks have faded.\nThe stock remains expensive against long-term profit expectations.\n\nDrew Angerer/Getty Images News\nThese days, the market certainly has no shortage of expensive growth stocks that have very little substance. One stock that I think is at particular risk of crumbling further is Beyond Meat (BYND), one of the first purveyors of the faux-meat trend and one of the most recognizable brands in the space.\nDespite the growing appeal of plant-based meats, I continue to see huge fundamental flaws in this stock. The market seems to agree, as Beyond Meat shares have slid by roughly half relative to all-time highs around ~$200 notched last October.\nData by YCharts\nIn my view, Beyond Meat shares have even more downside left. I continue to cite that there's a \"story\" risk to Beyond Meat: plant-based meats are popular now, but are they a passing dietary fad? The list of diet fads is a long one, ranging from keto diets and paleo diets to complete-nutrient drinks like Huel. While Beyond Meat may find itself a core customer base, I view the category's growth to be limited especially with concerns that plant-based meats are unhealthy from a sodium angle.\nYet there are shorter-term risks here, too. In particular, investors should be aware that Beyond Meat's growth and demand indicators have weakened in recent quarters. Profit margin slippage is another big concern, especially when the stock is still trading so expensively as a multiple of outer-year profits.\nThe bottom line here: Beyond Meat is a spoiling stock, and I think there's little the company can do to get back on the right track.\nSlowing growth, decaying velocity\nThe first thing investors should note is that Beyond Meat has missed Wall Street's expectations for three quarters in a row. It's a small wonder that the stock has landed in investors' \"penalty box\" - in a time when a reliable \"beat and raise\" cadence has become expected for growth stocks, Beyond Meat's earnings gaffes are a huge sore spot.\nIn Beyond Meat's most recent quarter (Q1), the company saw relatively tepid 11% y/y growth to $108.2 million in revenue, missing Wall Street's expectations of $113.3 million (+17% y/y) by a huge six-point margin. As shown below, that's an even wider miss than the $2 million gap to expectations in Q4:\nFigure 1. Beyond Meat earnings vs. expectations\nSource: Seeking Alpha\nAt a channel level, in Q1, Beyond Meat its U.S. retail sales grow by 28% y/y, but foodservice sales domestically saw a -26% y/y decline. This is concerning because throughout the March quarter, most areas and restaurants around the country had already lifted lockdown restrictions. We note that the kinds of chain locations that Beyond Meat is typically sold at, from Carls' Jr. to Dunkin' Donuts (DNKN), largely remained open during the pandemic anyway. So Beyond Meat can't really say that lockdowns and the pandemic were to blame for weaker foodservice sales: perhaps the pandemic had ended up ultimately changing consumers' menu preferences toward \"real\" meat, which is often also substantially cheaper than Beyond Meat.\nOn the retail side, we note that Beyond Meat's velocity is dropping (a measure of how quickly inventory is selling through on store shelves). Beyond Meat argued that during the pandemic, retail sell-through was constrained by limited supply - but now, what you can see in the chart below is that retail velocity has dramatically dropped over the past four weeks. The company noted that on a year over year basis, velocity is down -18% y/y in Q1.\nFigure 2. Beyond Meat retail velocity\nSource: Beyond Meat Q1 investor presentation\nWe note as well that Beyond Meat's market share growth in the retail space has slowed as well. The past four weeks only saw Beyond Meat expanding its market share by 127bps, versus 319bps over the past year.\nMargin decay\nSlowing growth isn't the only troubling indicator for Beyond Meat. The company's gross margin profile, already thin to begin with, is at risk as well. We note that in Beyond Meat's most recent quarter, gross margin slipped to 30.2%, a huge 860bps reduction from 38.8% in the year-ago quarter.\nFigure 3. Beyond Meat margin trends\nSource: Beyond Meat Q1 investor presentation\nThe company cited a myriad of reasons behind the decay. The company blamed the decay on rising storage/warehousing and transportation costs, which is similar to what many other consumer products companies are citing. Even more concerning, however, the company has cited rising fixed overhead costs at its production facilities. And perhaps riskiest of all is the fact that Beyond Meat notes that unfavorable product mix and higher trade discounts have also worked to push margins down.In spite of the fact that Beyond Meat leaned in more heavily on trade discounts to grow sales, the company still saw tepid revenue growth and thinning market share gains.\nWe note as well that Beyond Meat's adjusted EBITDA gains of $13.9 million from last Q1 turned into a -$10.8 million loss in the most recent Q1, indicating a 24-point decay in adjusted EBITDA margins. We have to wonder: is Beyond Meat structurally set up to be a profitable business?\nThe company likes to tout the fact that it spends ~8% of its revenue on R&D as a positive signal of the brand's innovation. But the other brands shown on the company's below slide are also innovators. Food brands like Kellogg and Kraft Heinz are constantly coming up with new cereal types and new flavors of their existing foods. Beyond Meat doesn't have a sole claim to innovation in the food space - yet it's spending considerably more than its peers on R&D. When we note the fact that Beyond Meat's gross margin is only ~30% to begin with, spending a further 8% of revenue on R&D is a steep ask.\nFigure 4. Beyond Meat R&D spend\nSource: Beyond Meat Q1 investor presentation\nValuation and key takeaways\nAnalysts aren't really expecting Beyond Meat to generate significant profits until years down the road. As shown in the chart below, the company is only expected to pass breakeven in 2023.\nFigure 5. Beyond Meat earnings estimates\nSource: Seeking Alpha\nAnd even against 2026 earnings expectations of $5.30 per share, and even after Beyond Meat's correction from all-time highs above $200, the stock's current price at ~$125 sits at a steep 23.6x P/E ratio against earnings five years down the line.\nWith the risks of Beyond Meat's slowing growth and unsteady gross margins, I think the chances of Beyond Meat justifying its current share price (let alone rallying substantially from current levels) are slim.\nContinue to avoid this stock.","news_type":1,"symbols_score_info":{"BYND":0.9}},"isVote":1,"tweetType":1,"viewCount":954,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"content":"NeeD to look closely at MA","text":"NeeD to look closely at MA","html":"NeeD to look closely at MA"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836493144,"gmtCreate":1629512075688,"gmtModify":1676530062224,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Is doing well&nbsp;","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Is doing well&nbsp;","text":"$Apple(AAPL)$Is doing well","images":[{"img":"https://static.tigerbbs.com/4baaf5f90403a983bb9abe9d0f7f6cf9","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/836493144","isVote":1,"tweetType":1,"viewCount":3458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":802926147,"gmtCreate":1627708893389,"gmtModify":1703495077106,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Check out undervalue SG stocks&nbsp;","listText":"Check out undervalue SG stocks&nbsp;","text":"Check out undervalue SG stocks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802926147","repostId":"1167653033","repostType":4,"repost":{"id":"1167653033","kind":"news","pubTimestamp":1627706886,"share":"https://ttm.financial/m/news/1167653033?lang=en_US&edition=fundamental","pubTime":"2021-07-31 12:48","market":"sg","language":"en","title":"SGD to weaken to $1.35/USD amidst COVID-19 woes: Fitch","url":"https://stock-news.laohu8.com/highlight/detail?id=1167653033","media":"Singapore Business","summary":"The Singapore dollar (SGD) is expected to weaken to $1.35 versus the US dollar (USD) for 2021, accor","content":"<p>The Singapore dollar (SGD) is expected to weaken to $1.35 versus the US dollar (USD) for 2021, according to Fitch Solutions, to weaken further to $1.36 in 2022.</p>\n<p>This is a downgrade from its previous forecast of $1.33 against the greenback for 2021 and $1.32 in 2022.</p>\n<p>“The SGD has weakened in line with most other Asian currencies after the Fed’s hawkish surprise on June 16, and will likely trade in a weaker range between $1.35 per USD and $1.38 per USD for the remainder of 2021 and likely in 2022 as well,” Fitch said.</p>\n<p>This is due to the risk-off sentiment sparked by the resurgence of COVID-19 infections across Asia, including the key economies of Indonesia, Malaysia, and Thailand.</p>\n<p>The SGD&nbsp;also breached the key support level of $1.35 per USD on 8 July and has weakened since. The last time Singapore breached this level was in July 2018, during the initial phases of the US-China trade war.</p>\n<p>“However, any weakness in the SGD should be capped by the economy being in a much more resilient position than other Asian markets, due to the fast progress in vaccinating the population,” it added. “This puts Singapore in a much more resilient position compared to most other Asian economies and the SGD could benefit from some degree of safe-haven flows from elsewhere in the region as the year progresses, limiting prospects for further depreciation beyond our identified trading range.”</p>\n<p>For the long term, Fitch expects a strong recovery in exports to support the currency in 2022, but balanced by the risk of a potentially more hawkish US Fed if above-2% target inflation persists.</p>\n<p>Fitch Solutions identified as a key risk the possibility of a COVID-19 variant that can bypass existing vaccines, which could force Singapore to implement further lockdowns.</p>","source":"lsy1618986048053","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SGD to weaken to $1.35/USD amidst COVID-19 woes: Fitch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSGD to weaken to $1.35/USD amidst COVID-19 woes: Fitch\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-31 12:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://sbr.com.sg/economy/in-focus/sgd-weaken-135usd-amidst-covid-19-woes-fitch><strong>Singapore Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Singapore dollar (SGD) is expected to weaken to $1.35 versus the US dollar (USD) for 2021, according to Fitch Solutions, to weaken further to $1.36 in 2022.\nThis is a downgrade from its previous ...</p>\n\n<a href=\"https://sbr.com.sg/economy/in-focus/sgd-weaken-135usd-amidst-covid-19-woes-fitch\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://sbr.com.sg/economy/in-focus/sgd-weaken-135usd-amidst-covid-19-woes-fitch","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167653033","content_text":"The Singapore dollar (SGD) is expected to weaken to $1.35 versus the US dollar (USD) for 2021, according to Fitch Solutions, to weaken further to $1.36 in 2022.\nThis is a downgrade from its previous forecast of $1.33 against the greenback for 2021 and $1.32 in 2022.\n“The SGD has weakened in line with most other Asian currencies after the Fed’s hawkish surprise on June 16, and will likely trade in a weaker range between $1.35 per USD and $1.38 per USD for the remainder of 2021 and likely in 2022 as well,” Fitch said.\nThis is due to the risk-off sentiment sparked by the resurgence of COVID-19 infections across Asia, including the key economies of Indonesia, Malaysia, and Thailand.\nThe SGD also breached the key support level of $1.35 per USD on 8 July and has weakened since. The last time Singapore breached this level was in July 2018, during the initial phases of the US-China trade war.\n“However, any weakness in the SGD should be capped by the economy being in a much more resilient position than other Asian markets, due to the fast progress in vaccinating the population,” it added. “This puts Singapore in a much more resilient position compared to most other Asian economies and the SGD could benefit from some degree of safe-haven flows from elsewhere in the region as the year progresses, limiting prospects for further depreciation beyond our identified trading range.”\nFor the long term, Fitch expects a strong recovery in exports to support the currency in 2022, but balanced by the risk of a potentially more hawkish US Fed if above-2% target inflation persists.\nFitch Solutions identified as a key risk the possibility of a COVID-19 variant that can bypass existing vaccines, which could force Singapore to implement further lockdowns.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":720,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892098901,"gmtCreate":1628608810503,"gmtModify":1676529797101,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>like and comment&nbsp;","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>like and comment&nbsp;","text":"$Apple(AAPL)$like and comment","images":[{"img":"https://static.tigerbbs.com/23179b079b92d3ca411908da43a7ccfe","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/892098901","isVote":1,"tweetType":1,"viewCount":2296,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":893920812,"gmtCreate":1628230797336,"gmtModify":1703503609267,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/42C.SI\">$IX BIOPHARMA LTD.(42C.SI)$</a>Soon it will change around&nbsp;","listText":"<a href=\"https://laohu8.com/S/42C.SI\">$IX BIOPHARMA LTD.(42C.SI)$</a>Soon it will change around&nbsp;","text":"$IX BIOPHARMA LTD.(42C.SI)$Soon it will change around","images":[{"img":"https://static.tigerbbs.com/f582ab96c3b605ba736a3d8e0f38f168","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/893920812","isVote":1,"tweetType":1,"viewCount":3379,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":899874679,"gmtCreate":1628175879391,"gmtModify":1703502668519,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899874679","repostId":"1173170520","repostType":4,"isVote":1,"tweetType":1,"viewCount":1000,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804097553,"gmtCreate":1627911389972,"gmtModify":1703497703918,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"Buying SQ is a good idea now with plans to do open international flights&nbsp;","listText":"Buying SQ is a good idea now with plans to do open international flights&nbsp;","text":"Buying SQ is a good idea now with plans to do open international flights","images":[{"img":"https://static.tigerbbs.com/d15c987e3f58a1513c34332b10385a41","width":"750","height":"1744"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/804097553","isVote":1,"tweetType":1,"viewCount":1249,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":802927435,"gmtCreate":1627709442327,"gmtModify":1703495082640,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/42C.SI\">$IX BIOPHARMA LTD.(42C.SI)$</a>Looking at this undervalued sg stock","listText":"<a href=\"https://laohu8.com/S/42C.SI\">$IX BIOPHARMA LTD.(42C.SI)$</a>Looking at this undervalued sg stock","text":"$IX BIOPHARMA LTD.(42C.SI)$Looking at this undervalued sg stock","images":[{"img":"https://static.tigerbbs.com/f582ab96c3b605ba736a3d8e0f38f168","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/802927435","isVote":1,"tweetType":1,"viewCount":919,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":806644835,"gmtCreate":1627655344227,"gmtModify":1703494256452,"author":{"id":"4090242229859660","authorId":"4090242229859660","name":"pop3","avatar":"https://static.tigerbbs.com/31b0c6e3208f47bb4772de4a61d92518","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090242229859660","authorIdStr":"4090242229859660"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>thanks tiger for free apple stock&nbsp;","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>thanks tiger for free apple stock&nbsp;","text":"$Apple(AAPL)$thanks tiger for free apple stock","images":[{"img":"https://static.tigerbbs.com/44074829f27bec09cb1a1d1f90342bfe","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/806644835","isVote":1,"tweetType":1,"viewCount":398,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}